CD63 and central nervous system cancer: Rorive et al. investigated the expression of CD63 on ten tissue microarrays consisting of 471 gliomas and found the CD63 expression to increase significantly with astrocytoma grade being significantly highest in glioblastomas and anaplastic astrocytomas compared to diffuse astrocytoma.